AAV9 Capsid Variants with Improved CNS Transduction Identified by Directed Evolution

被引：0

作者：

Rohovie, Marcus ^{[1
]}

Kruse, Nikki ^{[1
]}

Schmitt, Christopher ^{[1
]}

Wong, Victoria ^{[1
]}

Sero, Antoinette ^{[1
]}

Rivera-Velazquez, Mirella ^{[1
]}

Lee, Grace ^{[1
]}

Desautel, Sarah ^{[1
]}

Del Greco, Elizabeth ^{[1
]}

Sedighi, Faezeh ^{[1
]}

Nivina, Aleksandra ^{[1
]}

Jenne, Stephan ^{[1
]}

Gebretsadik, Kahsay ^{[1
]}

Kumar, Ambuj ^{[1
]}

Chng, Chinping ^{[1
]}

Akeefe, Hassibullah ^{[1
]}

Silverman, Adam ^{[1
]}

机构：

[1] Codexis Inc, San Carlos, CA USA

来源：

MOLECULAR THERAPY | 2023年 / 31卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

1400

引用

页码：661 / 661

页数：1

共 50 条

[21] CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain
Mathiesen, Sophie N.
Lock, Jasmine L.
Schoderboeck, Lucia
Abraham, Wickliffe C.
Hughes, Stephanie M.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 19 : 447 - 458
[22] Directed Evolution of AAV9 for Efficient Gene Expression in Cardiomyocytes In Vitro and In Vivo
Huettermann, Leonard
Schroeder, Lena C.
Shetty, Prithviraj M. V.
Jonker, Timo
Hille, Susanne S.
Kliesow Remes, Anca
Matzen, Andrea
Grimm, Dirk
Frank, Derk
Boink, Gerard J. J.
Eschenhagen, Thomas
Schade, Dennis
Mueller, Oliver J.
HUMAN GENE THERAPY, 2025,
[23] Effect of Age on Intrathecal AAV9 Transduction in Mice
Garza, Irvin T.
Holmes, Sydni
Knight, Krishanna
Bailey, Rachel M.
MOLECULAR THERAPY, 2022, 30 (04) : 442 - 443
[24] AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytes
Rode, Laura
Baer, Christian
Gross, Sonja
Rossi, Axel
Meumann, Nadja
Viereck, Janika
Abbas, Naisam
Xiao, Ke
Riedel, Isabelle
Gietz, Anika
Zimmer, Karina
Odenthal, Margarete
Buening, Hildegard
Thum, Thomas
MOLECULAR THERAPY, 2022, 30 (12) : 3601 - 3618
[25] Characterization of Novel Human-Derived AAV2 Variants with Brain Transduction Profiles that are Comparable to AAV9
Xu, Meiyu
Brown, Alexander
Luo, Li
Xu, Guangchao
Qin, Wanru
Xiao, Yuanyuan
Wang, Chunmei
Li, Jia
Ma, Hong
He, Ran
Su, Qin
Wei, Yuquan
Tai, Phillip W. L.
Gao, Guangping
MOLECULAR THERAPY, 2019, 27 (04) : 89 - 90
[26] Stepwise Evolution of the AAV5-Derived Capsid VCAP-100 Identifies Novel Variants with Improved CNS Transduction and Liver Detargeting Following Systemic Injection
Maura, Damien
Yu, Jennifer C.
Child, Matthew
Kaur, Roop
Thorpe, Zachary
Ren, Xiaoqin
Gebremedhin, Netsanet
Li, Jiangyu
Liu, Jiachen
Fiore, Timothy
Kavanagh, Dillon
Kubiak, Alexander
Grant, Kyle
Sayed-Zahid, Ambreen
Moyer, Tyler
Graham, Kristin P.
Kutchin, Alexander
Yao, Johnny
Carter, Todd A.
Nonnenmacher, Mathieu E.
MOLECULAR THERAPY, 2023, 31 (04) : 238 - 239
[27] Modification of AAV9 capsid at different positions affects differently to AAV infectivity in culture
Milagros, S.
Ramirez, P.
Guembe, M.
Uribarri, A.
Carte, B.
Mauleon, I.
Mendez, M.
Aldabe, R.
HUMAN GENE THERAPY, 2024, 35 (3-4) : A87 - A87
[28] Directed Evolution of Rationally-Engineered AAV Capsid Variants with Enhanced Central Nervous System (CNS) Tropism Following Systematic Administration
Wang, Hongxing
Zhu, Sha
Zhang, Weiqun
Toro, Gabriela C.
Liu, Na
Zhao, Lingzhi
Shen, Joan
MOLECULAR THERAPY, 2024, 32 (04) : 480 - 480
[29] RNA-Based AAV Capsid Libraries Selection for Improved AAV Bioengineering via Directed Evolution
Westhaus, Adrian
Sallard, Erwan
Cabanes-Creus, Marti
Rybicki, Arkadiusz
Santilli, Giorgia
Thrasher, Adrian J.
Lisowski, Leszek
MOLECULAR THERAPY, 2020, 28 (04) : 441 - 441
[30] Assessment of Adipocyte Transduction Using Different AAV Capsid Variants
Boychenko, Stanislav
Abdullina, Alina
Laktyushkin, Viktor S.
Brovin, Andrew
Egorov, Alexander D.
PHARMACEUTICALS, 2024, 17 (09)

← 1 2 3 4 5 →